Investigational Drug Details
| Drug ID: | D034 |
| Drug Name: | BFKB8488A |
| Synonyms: | -- |
| Type: | Biological drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | KLB inhibitor; Type 1 FGFR antagonist |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 2 on-going (NCT04171765) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0203 | NCT04171765 | Phase 2 | Active, not recruiting | No Results Available | September 30, 2020 | February 4, 2022 | Details |
| L0387 | JPRN-jRCT2051210005 | Phase 1 | Recruiting | No Results Available | 09/04/2021 | 10 January 2022 | Details |
| L0452 | EUCTR2019-001897-27-FR | Phase 2 | Authorised | No Results Available | 07/10/2019 | 18 May 2020 | Details |
| L0831 | NCT03060538 | Phase 1 | Not recruiting | No Results Available | 17/02/2017 | 12 December 2020 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|